AmericasENPublic drug registration overview
Argentina Pharmaceutical Registration Pathway
Market Overview Market profile: Argentina is shaped by public procurement, private insurance, price controls, and FX constraints. Local pharmaceutical capability is strong, while i...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: Argentina Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Regulatory maturity: Medium-high. ANMAT is the national regulator for medicines, food, and medical technology.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
- Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
- Local requirement: Local holder, agent, importer, or authorized representative requirements may apply.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Market profile: Argentina is shaped by public procurement, private insurance, price controls, and FX constraints. Local pharmaceutical capability is strong, while imported products need careful local representative and certificate control.
- Regulatory maturity: Medium-high. ANMAT is the national regulator for medicines, food, and medical technology.
- Core decision: Classify the product as new drug, generic, biologic, vaccine, prescription, OTC, or controlled medicine before choosing dossier and local responsibility structure.
Regulator
- Authority: ANMAT, Administración Nacional de Medicamentos, Alimentos y Tecnología Médica
- Official portal: https://www.argentina.gob.ar/anmat/en
Product Types and Review Pathways
| Type | Pathway focus |
|---|---|
| New drug | Quality, safety, efficacy, and foreign approval evidence |
| Generic | Quality, equivalence, reference product, and labeling |
| Biologic | Comparability, clinical evidence, cold chain, and batch consistency |
| Imported medicine | Local representative, GMP, CPP, and Spanish materials |
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.